Archive for December, 2009

Solution to killer superbug found in Norway

By MARTHA MENDOZA and MARGIE MASON, Associated Press Writers Martha Mendoza And Margie Mason, Associated Press Writers – 

OSLO, Norway Aker University Hospital is a dingy place to heal. The floors are streaked and scratched. A light layer of dust coats the blood pressure monitors. A faint stench of urine and bleach wafts from a pile of soiled bedsheets dropped in a corner.

Look closer, however, at a microscopic level, and this place is pristine. There is no sign of a dangerous and contagious staph infection that killed tens of thousands of patients in the most sophisticated hospitals of Europe, North America and Asia this year, soaring virtually unchecked.

The reason: Norwegians stopped taking so many drugs.

Twenty-five years ago, Norwegians were also losing their lives to this bacteria. But Norway’s public health system fought back with an aggressive program that made it the most infection-free country in the world. A key part of that program was cutting back severely on the use of antibiotics.

Now a spate of new studies from around the world prove that Norway’s model can be replicated with extraordinary success, and public health experts are saying these deaths — 19,000 in the U.S. each year alone, more than from AIDS — are unnecessary.

Read more at : http://news.yahoo.com/s/ap/20091230/ap_on_he_me/when_drugs_stop_working_norway_s_answer

lineblog

Your email:

 

Broken Links ? Questions ?

TO CONTACT JMB CLICK ON THE STAMPmail

FDA Required Disclosure

jmbblog

A podcast powered by FeedBurner

Add to Del.cio.us RSS Feed Add to Technorati Favorites Stumble It! Digg It!
    www.sajithmr.com

Send article as PDF to PDF Printer
Did you like this? If so, please bookmark it,
tell a friend
about it, and subscribe to the blog RSS feed.

Leave your Comment

FDA approves Crestor for people who have NO health problem to correct

b1ig Pharma has been trending this direction for a long time: marketing medicines to people who don’t need them and who have nothing wrong with their health. It’s all part of a ploy to position prescription drugs as nutrients — things you need to take on a regular basis in order to prevent disease.

The FDA recently gave its nod of approval on the matter, announcing that Crestor can now be advertised and prescribed as a “preventive” medicine. No longer does a patient need to have anything wrong with them to warrant this expensive prescription medication: They only need to remember the brand name of the drug from television ads.

This FDA approval for the marketing of Crestor to healthy people is a breakthrough for wealthy drug companies. Selling drugs only to people who are sick is, by definition, a limited market. Expanding drug revenues requires reaching people who have nothing wrong with them and convincing them that taking a cocktail of daily pharmaceuticals will somehow keep them healthy.

All this is, of course, the greatest quackery we’ve yet seen from Big Pharma, because once this floodgate of “preventive pharmaceuticals” is unleashed, the drug companies will be positioned to promote a bewildering array of other preventive chemicals you’re supposed to take at the same time. Did you take your anti-cancer pill today? How about your anti-diabetes pill? Anti-cholesterol pill? Don’t forget your anti-Alzheimer’s pill, too.

Medications are not vitamins

t1he very idea that these drugs can somehow prevent a person from becoming sick in the future strains the boundaries of scientific credibility. Only natural therapies like nutrition can prevent the onset of disease, not patented chemicals that don’t belong in the human body in the first place.

The logical argument of the drug companies who push these “preventive” prescriptions is essentially that the human body is deficient in pharmaceuticals, and that deficiency can only be corrected by taking whatever brand-name drugs they show you on television. Forget about deficiencies in zinc, or vitamin D, or living enzymes; what your body really needs is more synthetic chemicals!

The FDA agrees with this loopy logic. And why wouldn’t it? Subscribing to this pharmaceutical delusion is an easy way to instantly expand Big Pharma’s customer base by tens of millions. Overnight, the market for Crestor ballooned from a few million people with high cholesterol to the entire U.S. population of 300 million people.

If Crestor can help healthy people be healthier (which it can’t, but let’s play along with this delusion for the sake of argument), then it’s only a matter of time before they start adding Crestor to infant formula. I mean, why not? If it’s so good for healthy people, then it must make babies healthier, too, right?

So let’s add Crestor to sports drinks. Let’s sprinkle it into the iodized salt supply. Let’s drip it into the municipal water! (Don’t laugh: This idea of dripping cholesterol drugs into the water supply has already been suggested by more than one doctor.) Let’s merge the pharmaceutical supply with the food supply and charge people prescription drugs prices for “functional” foods laced with these chemicals!

Pharmaceutical deficiency

t1hat’s really where all this is headed. When medicines are approved as preventive “nutrients” for the human body, it’s only a matter of time before the industry starts talking about your “pharmaceutical deficiency.”

Not taking any medications? You have a pharmaceutical deficiency, and it needs to be corrected by taking more prescription drugs. But don’t bother with actual nutrition, because nutrients have absolutely no role in preventing disease, the FDA claims. No nutrient has ever been approved by the FDA for the prevention or treatment of any disease whatsoever.

The message from the FDA is quite clear on this: Nutrients are useless, and you should eat medications as if they were vitamins.

Patented Big Pharma chemicals, after all, provide all the nutrition you’ll ever need!video_testimonials

Fish oil and omega 3 better than statins, lipitor?

Read also : http://www.jmbblog.com/coronary-heart-disease-best-kept-secrets-part-3-drugs/

lineblog

Your email:

 

Broken Links ? Questions ?

TO CONTACT JMB CLICK ON THE STAMPmail

FDA Required Disclosure

jmbblog

A podcast powered by FeedBurner

Add to Del.cio.us RSS Feed Add to Technorati Favorites Stumble It! Digg It!
    www.sajithmr.com

Send article as PDF to PDF Printer
Did you like this? If so, please bookmark it,
tell a friend
about it, and subscribe to the blog RSS feed.

Leave your Comment

cancer_curesWhat people use when they have cancer and want to get well with alternative treatment


Mycoplasma – Vaccine

For 30 years, scientists around the world have been studying the relationship between Mycoplasma (a type of bacteria) and different diseases such as cancer, auto-immune diseases (arthritis, lupus, sclerodemia, etc.), multiple sclerosis, ALS, chronic f atigue syndrome, candidiasis, etc.
Mycoplasma is the smallest free-living bacteria (0.2 Um); normal bacteria range between 1.0 – 5.0 Um.).

Mycoplasmas have certain characteristics:

Not classified as gram (-) or Gram (+) because they have no cell wall.

Only Bacteria with cholesterol in the cell membrane and can be cultured in vitro, in special medium with sterols.

Strict aerobe (needing oxygen to live).

Metabolizes glucose (special characteristic).

Originally this bacteria was classified as a virus (because of the small size), and as pleuro-pneumoniae organism (because was first found to be related to pneumonia). In 1960, Klineberg gave this bacteria the name of Mycoplasma (bacteria). Due to the small size and the lack of a cell wall, this microorganism is capable of infecting a great number of cells (any part of the body) and live as a parasite (saprophyte) in the surface of the cells. (Baril, 1979; Rarin, 1981). The Mycoplasmas can become a parasite in plants, insects, animals, and humans, and can trigger different diseases. Once the Mycoplasma becomes a parasite in the cell, morphologic and physiologic changes are developed, and takes on the differentiation of various diseases-example, infections (mainly pneumonia-like, urethritis, pyelonefphritis, etc.) Arthritis, Lupus and other immune-diseases. In cancer, the tumor cells infected by Mycoplasma are more susceptible to spreading and producing metastases in different parts of the body (Slackpoles: Cli. Exp. Metastasis 6:271: 1988). This is also true with Chronic Fatigue Syndrome (especially when the symptoms are severe), Multiple Sclerosis, and ALS (Amyotrophic Lateral Sclerosis).

When a Mycoplasma parasite enters the cells, immune components as lymphocytes produce alterations in their functions, and perturbation of the normal immune response is made. Such anergia (absence of immune response) or hypernergia (excess of immune response), are both novices for individuals which had been infected with Mycoplasma (Dudlex, EMBO J. It 3963, 1988) (Cole. Infect> immun. 36:852,1982).

Once the Mycoplasmas get inside the cells (as a parasite) it is very difficult to cultivate and even some special tests are negative (conventional antibody tests, cultures requiring sterols). It takes 10 days at least to grow the culture. Sometimes they are positive in the cold-agglutinin test and complement fixation test (fried eggs colonies). Recently Dr. G. Nicolson developed a new method called PCR-DNA.

At SDC (San Diego Clinic) we have been working with a special diagnostic test called the Platelet Test. This test was developed in Germany in the 1960’s for O. Snegotska and P.W. Scheidl. (folia clinica International, Spain. XVI, No6, June 1966). Throughout the readings of experiments by physicians or pathologists, it is possible to detect the different form and shapes that Platelets develop once they are infected by Mycoplasma bacteria. In the last 30 years researchers in Germany and other parts of the world have been able to classify these forms and shapes that Mycoplasma bacteria make in the platelets, and see how they are related to patients that have the disease (or have a tendency to develop the disease).

The test is very acute and has 95 % effectiveness in Cancer (all types), Auto-immune diseases (Arthritis. Lupus etc.), Multiple Sclerosis, ALS, Chronic fatigue syndrome, etc.).

By drawing blood from patients with different diseases (cancer, arthritis, etc.) and infecting the blood with Mycoplasma bacteria (discovered through Platelet Tests), Dr. Streglay, in 1970, developed a Biologic product called Mycoplasma Vaccine (Myc-Vacc). This Biologic product in principle destroys specifically the Mycoplasmic bacteria related to the disease (permitting the cell to work freely); on the other hand, it produces a substance that will work in the immune system ( helping to balance and reinforce) through the immune-comprise cells, thus producing aliviation of the symptoms in the patient.

To develop this Biologic product it is necessary to draw 50 -100 cc of blood from the patient. The process time is approximately six weeks to develop the vaccine; special mediums and centrifugation techniques are necessaries.

more-sourceshttp://www.sdiegoclinic.com

lineblog

Your email:

 

Broken Links ? Questions ?

TO CONTACT JMB CLICK ON THE STAMPmail

FDA Required Disclosure

jmbblog

A podcast powered by FeedBurner

Add to Del.cio.us RSS Feed Add to Technorati Favorites Stumble It! Digg It!
    www.sajithmr.com

Send article as PDF to PDF Download
Did you like this? If so, please bookmark it,
tell a friend
about it, and subscribe to the blog RSS feed.

Leave your Comment

cancer_curesWhat people use when they have cancer and want to get well with alternative treatment:Pranayama Yoga

Pranayama – Baba Ramdev


Kapalbhati- (Rapid Exhalation)

lineblog

Your email:

 

Broken Links ? Questions ?

TO CONTACT JMB CLICK ON THE STAMPmail

FDA Required Disclosure

jmbblog

A podcast powered by FeedBurner

Add to Del.cio.us RSS Feed Add to Technorati Favorites Stumble It! Digg It!
    www.sajithmr.com

Send article as PDF to PDF
Did you like this? If so, please bookmark it,
tell a friend
about it, and subscribe to the blog RSS feed.

Leave your Comment

Get Adobe Flash playerPlugin by wpburn.com wordpress themes